Does bilateral internal thoracic artery grafting increase long-term survival of diabetic patients?

Ioannis K Toumpoulis1, Constantine E Anagnostopoulos, Sandhya Balaram

  • 1Department of Cardiac Surgery, College of Physicians and Surgeons of Columbia University, St. Luke's-Roosevelt Hospital Center, New York, New York, USA.

Insights

Bilateral internal thoracic artery (BITA) bypass surgery did not significantly improve long-term survival in diabetic patients compared to single internal thoracic artery (SITA) bypass. However, BITA showed improved survival in patients aged 60-69, while SITA was better for those over 79.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Diabetic Patient Outcomes

Background:

  • Coronary artery bypass grafting (CABG) is a common treatment for coronary artery disease.
  • The use of bilateral internal thoracic arteries (BITA) versus single internal thoracic artery (SITA) for CABG in diabetic patients is debated.
  • Long-term survival differences between BITA and SITA in diabetic populations require further investigation.

Purpose of the Study:

  • To compare the long-term survival rates of diabetic patients undergoing BITA versus SITA coronary artery bypass surgery.
  • To identify potential age-related differences in survival outcomes between BITA and SITA grafting in diabetic patients.

Main Methods:

  • A retrospective study matched 980 diabetic patients (490 BITA, 490 SITA) who underwent CABG between 1992 and 2002.
  • Propensity score matching was used to control for baseline differences between groups.
  • Long-term survival data were collected via the National Death Index with a mean follow-up of 4.7 years.

Main Results:

  • Overall, BITA grafting showed no significant impact on long-term survival compared to SITA (HR 0.89, p=0.343).
  • No significant differences in 30-day mortality or major postoperative complications were observed.
  • Five-year survival rates were similar overall (79.9% BITA vs. 75.7% SITA), but varied by age group: improved for 60-69 year olds with BITA (84.1% vs. 71.0%), and worse for those over 79 (43.1% vs. 70.0%).

Conclusions:

  • BITA coronary artery bypass grafting does not significantly affect long-term survival in the general diabetic patient population.
  • BITA grafting may offer a survival benefit for diabetic patients aged 60 to 69 years.
  • SITA grafting may be more beneficial for diabetic patients older than 79 years.
Abstract

Related Concept Videos